ESC Premium Access

Red blood cell transfusions increase platelet reactivity in patients treated with dual antiplatelet therapy

Congress Presentation

About the speaker

Miss Marine Quillot

Rangueil Hospital of Toulouse, Toulouse (France)
0 follower

9 more presentations in this session

Equal safety of rivaroxaban and vitamin K antagonists with regard to the risk of intracranial- and gastrointestinal bleeding in patients with venous thromboembolism - A Danish nationwide study

Speaker: Ms C. Sindet-Pedersen (Hellerup, DK)


Risk of venous thromboembolism recurrences in patients who continued versus discontinued rivaroxaban therapy after an initial six-month therapy

Speaker: Doctor C. Crivera (Raritan, NJ, US)


Very low-dose recombinant factor VIIa for optimized treatment of cardiovascular patients at high risk of hemorrhage

Speaker: Doctor A. Assmann (Duesseldorf, DE)


Efficacy and bleeding risk of newer anticoagulants compared to conventional treatment in patients with chronic kidney disease- a meta analysis of randomized controlled trials

Speaker: Assistant Professor K. Prudhvi (Tucson, US)


Management of acute venous thromboembolism in Europe - follow-up data at 1 month from the PREFER in VTE registry

Speaker: Doctor A. Cohen (London, GB)


Access the full session

Antithrombotics in daily clinical practice

Speakers: Miss M. Quillot, Ms C. Sindet-Pedersen, Doctor C. Crivera, Doctor A. Assmann, Assistant Professor K. Prudhvi...

About the event


ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb